Japanese Biotech Stock News

On 5 June 2026, Hitachi, Ltd. announced it had entered a collaboration with Intel Corporation to develop physical AI, advanced computing, and next-generation digital infrastructure solutions across manufacturing, energy, mobility and other industries, combining Hitachi’s IT/OT strengths with Intel’s silicon and computing platforms. A particularly interesting element is the planned joint work on foundry tools and quantum computing, where Hitachi’s ExTOPE platform and metrology data will be...

Sumitomo Realty & Development has recently continued to report negative results for a fifth consecutive quarter, even as the broader Nikkei 225 index has moved higher, underscoring ongoing financial pressures relative to the wider market. This persistent run of weak earnings against a rising benchmark highlights how company‑specific challenges can diverge sharply from broader sector and index trends. We will now examine how this prolonged period of negative results shapes Sumitomo Realty &...

Mitsubishi Electric (TSE:6503) plans to launch its 5th generation silicon carbide MOSFETs for electric vehicle drive systems, targeting higher efficiency and smaller components. The company has opened "Serendie Street Boston," its first US based digital transformation hub, focused on connecting research, startups, and industry partners. Mitsubishi Electric enters this phase of product and business development with its shares at ¥6,014.0. The stock is up 25.6% year to date and 108.5% over...

SHIFT (TSE:3697) is back in focus after the company and Rise Consulting Group agreed to deepen their collaboration across talent, sales, delivery, and AI. They aim to use shared management resources to support mutual business growth. See our latest analysis for SHIFT. The recent collaboration news comes after a mixed run for SHIFT's stock, with a 1-month share price return of 11.23% and a year-to-date share price return down 24.42%. The 1-year total shareholder return declined 58.50%,...

Upcoming earnings call and recent share performance The Hyakugo Bank (TSE:8368) 2026 earnings call on June 2 has focused attention on the stock, as investors weigh upcoming commentary against a year of strong share price and total return figures. See our latest analysis for Hyakugo Bank. With the upcoming earnings call in focus, Hyakugo Bank’s ¥1,928.0 share price sits on the back of strong recent momentum, including a 6.46% 1 month share price return and a 63.81% year to date share price...

Subaru of America reported a surge in U.S. vehicle sales in May. Hybrid and electric models reached a record share of the sales mix, accounting for nearly 25% of deliveries. The figures highlight progress in Subaru's electrification push in a key export market for TSE:7270. For investors tracking TSE:7270, the stronger May showing in the U.S. puts a spotlight on Subaru's mix of all wheel drive vehicles and its growing electrified lineup. The auto sector has been steadily rolling out more...

Panasonic Holdings (TSE:6752) expanded its air quality portfolio with the BalancedHome 210 ERV from Panasonic Eco Systems North America, aimed at residential and light commercial projects. Panasonic Avionics Corporation launched its Astrova in-flight engagement solution on Saudia's Airbus A321XLR, marking the first use of its modular platform and advanced mapping technology in Saudi Arabia. For readers tracking TSE:6752, these product launches illustrate how Panasonic is focusing on...

SoftBank Group (TSE:9984) has become Japan's most valuable listed company after committing up to €75b to build 5 GW of AI data center capacity in France, drawing fresh attention to its stock. See our latest analysis for SoftBank Group. SoftBank Group’s recent AI announcements come on top of a powerful run, with a 36.91% 1 month share price return and a very large 1 year total shareholder return, although the stock did slip 0.87% over the past week as some investors locked in gains. If you are...

Shionogi (TSE:4507) has received U.S. FDA approval for XOCOVA (ensitrelvir) as the first oral antiviral for post exposure prophylaxis of COVID-19. The company also secured regulatory approval in China for Naldemedine Tosilate to treat opioid induced constipation. These approvals expand Shionogi's marketed portfolio across infectious disease and pain management related conditions. For investors tracking Shionogi at a share price of ¥2,855.0, these dual approvals arrive after a mixed shorter...

Investors watching Senshu ElectricLtd (TSE:9824) just got a fresh set of numbers for Q2 2026, with revenue of ¥40.5 billion and net income of ¥2,543 million, translating to basic EPS of ¥148.70. The company has seen revenue move from ¥32.2 billion in Q2 2025 to ¥40.5 billion in Q2 2026, while quarterly EPS shifted over the same period from ¥83.93 to ¥148.70, setting up this print against a backdrop of solid top line scale and earnings power that now needs to be weighed against slightly softer...

Q1 2027 headline numbers and earnings setup Sekisui House (TSE:1928) opened fiscal 2027 with Q1 revenue of ¥908.9 billion and basic EPS of ¥90.21, setting the tone for how the year may shape up after a strong run into the end of 2026. Over the last few reported quarters, revenue has ranged from ¥894.0 billion in Q1 2026 to ¥1.3 trillion in Q4 2026, while basic EPS moved between ¥51.49 and ¥131.17 over the same period, giving you a clear sense of how the top and bottom line have tracked...

Recent performance snapshot Mitsubishi (TSE:8058) has drawn fresh attention after a mixed stretch in the stock, with the share price down about 5% over the past month and roughly 4% over the past 3 months. See our latest analysis for Mitsubishi. Despite the recent pullback, the stock has a 33.4% year to date share price return. The 1 year total shareholder return of 73.8% and 5 year total shareholder return of over 4x point to strong longer term momentum. If this kind of performance has you...

Stock performance snapshot Kyowa Kirin (TSE:4151) has come under pressure recently, with the stock down about 0.7% on the day and about 8.8% over the past week, extending a weaker year-to-date trend. Over the past month the share price has fallen about 4.6%, although it is still up roughly 1.4% over the past 3 months. Over longer periods, total returns have declined about 3.8% over the past year, 9.5% over 3 years, and 31.9% over 5 years. See our latest analysis for Kyowa Kirin. For...

May sales update and Oshman's integration ABC-MartInc (TSE:2670) caught investor attention after reporting 8.8% year-on-year growth in domestic all-store and existing-store sales for May 2026, supported by roadside locations and metropolitan commercial facilities. The company also confirmed that, from the fiscal year ending February 2027, domestic results will include Oshman’s sales, reflecting a deeper integration of its lifestyle-focused operations within reported performance metrics. See...

Trigger: TOTO pivots investment toward semiconductor-related products TOTO (TSE:5332) recently said it plans to allocate over 50% of future capital expenditure to semiconductor-related products, shifting away from large bathroom projects in the US and China that are now finishing. This capital allocation change immediately drew attention to TOTO stock, as investors considered how a greater focus on semiconductor-related products might affect growth prospects, earnings mix, and the company’s...

Recent share performance sets the context Seiko Epson (TSE:6724) has drawn fresh attention after the stock gained around 44% over the past month and roughly 49% over the past 3 months, prompting investors to reassess what is already priced in. See our latest analysis for Seiko Epson. The recent move fits into a stronger run, with the share price delivering double digit gains over both the past month and year, while the latest 1-year total shareholder return of 70.54% points to building...

IHI (TSE:7013) is back in focus after its subsidiary, IHI Aerospace, received a five month suspension from bidding on Japan Aerospace Exploration Agency contracts following improper cost claims. This development has put a spotlight on compliance risks and visibility of future aerospace orders. See our latest analysis for IHI. Against this backdrop, IHI’s share price has been under pressure in recent weeks, with a 30 day share price return of down 11.7% and a 90 day share price return of down...

AI-fueled rally puts Kioxia in the spotlight Kioxia Holdings (TSE:285A) is in focus after a powerful rally tied to enthusiasm for its memory chips used in AI data centers briefly lifted its market value above Toyota Motor. See our latest analysis for Kioxia Holdings. At a share price of ¥76,940, Kioxia has seen very strong momentum, with a 30 day share price return of 111.32%, a 90 day share price return of 285.18%, and a year to date share price return of 577.89%. The 1 year total...

Recent share performance sets the stage ARCHION (TSE:543A) has drawn attention after the stock fell about 4% over the past day and 13% over the past week, even as it is slightly up over the past month. See our latest analysis for ARCHION. With the share price at ¥316.0, the recent 7-day share price return of negative 13.42% and the year-to-date share price return of negative 20.60% indicate that negative momentum has been building for some time. This is also reflected in the 1-year total...

Hub Co., Ltd.'s ( TSE:3030 ) robust earnings report didn't manage to move the market for its stock. Our analysis...

Tess Holdings Co.,Ltd. ( TSE:5074 ), might not be a large cap stock, but it received a lot of attention from a...

Upcoming Earnings Call Puts Ferrotec in Focus Ferrotec (TSE:6890) heads into its 2026 earnings call on May 29 with investor attention on how recent financial results and management commentary could relate to its semiconductor equipment and electronic components businesses. See our latest analysis for Ferrotec. Ferrotec’s strong recent momentum, including a 12.83% 1 day share price return and a 74.51% year to date share price return, sits alongside a very large 1 year total shareholder return...

Luminopia, Inc. recently announced an exclusive licensing agreement granting Rohto Pharmaceutical Co., Ltd. rights to develop and commercialize its digital therapy for pediatric amblyopia in Japan, with Rohto leading local clinical and regulatory efforts. This collaboration gives Rohto a new entry point into prescription-grade digital health therapies, broadening its traditional eye-care portfolio into software-based treatments. Next, we will examine how this move into digital pediatric eye...

Why Chugai Pharmaceutical Stock Is Drawing Attention Now Recent share price moves have pushed Chugai Pharmaceutical (TSE:4519) further away from its recent highs, which is prompting some investors to recheck the fundamentals behind this large Japan based pharmaceutical group. See our latest analysis for Chugai Pharmaceutical. At a share price of ¥7,567, Chugai Pharmaceutical has seen its short term momentum fade, with the 30 day share price return down 8.22% and the 90 day share price return...